Novel Oncogene Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures
Xiaoming Ju, Adam Ertel, Mathew Casimiro, Zuoren Yu, Hui Meng, Peter A. McCue, Rhonda Walters, Paolo Fortina, Michael P. Lisanti and Richard G. Pestell
Cancer research (Chicago, Ill.), v 73(2), pp 978-989
Herein, murine prostate cancer cell lines, generated via selective transduction with a single oncogene (c-Myc, Ha-Ras, and v-Src), demonstrated oncogene-specific prostate cancer molecular signatures that were recapitulated in human prostate cancer, and developed lung metastasis in immune competent mice. Interrogation of two independent retrospective cohorts of patient samples using the oncogene signature demonstrated an ability to distinguish tumor from normal prostate with a predictive value for prostate cancer of 98 – 99%. In a blinded study, the signature algorithm demonstrated independent substratification of reduced recurrence free survival by Kaplan-Meier analysis. The generation of new oncogene-specific prostate cancer cell lines that recapitulate human prostate cancer gene expression, that metastasize in immune-competent mice, are a valuable new resource for testing targeted therapy while the molecular signatures identified herein provides further value over current gene signature markers of prediction and outcome.
Novel Oncogene Induced Metastatic Prostate Cancer Cell Lines Define Human Prostate Cancer Progression Signatures
Creators
Xiaoming Ju - Thomas Jefferson University
Adam Ertel - Thomas Jefferson University
Mathew Casimiro - Kimmel Cancer Center
Zuoren Yu - Kimmel Cancer Center
Hui Meng - Kimmel Cancer Center
Peter A. McCue - Thomas Jefferson University
Rhonda Walters - Thomas Jefferson University
Paolo Fortina - Thomas Jefferson University
Michael P. Lisanti - Thomas Jefferson University
Richard G. Pestell - Thomas Jefferson University
Publication Details
Cancer research (Chicago, Ill.), v 73(2), pp 978-989
Publisher
American Association for Cancer Research (AACR)
Grant note
R01 CA086072 || CA / National Cancer Institute : NCI
P30 CA056036 || CA / National Cancer Institute : NCI
R01 CA070896 || CA / National Cancer Institute : NCI
R01 CA075503 || CA / National Cancer Institute : NCI
R01 CA107382 || CA / National Cancer Institute : NCI
Resource Type
Journal article
Language
English
Academic Unit
School of Biomedical Engineering, Science, and Health Systems
Web of Science ID
WOS:000313739500055
Scopus ID
2-s2.0-84872563780
Other Identifier
991019176803604721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Web of Science research areas
Oncology
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services